Speaker illustration

Doctor Leslie Marisol Lugo Gavidia

Royal Perth Hospital, Perth (Australia)

Impact of the type of acute coronary syndrome on the pharmocodynamic response to P2Y12 inhibitors in the acute and maintenance phase of therapy

Event: ESC Congress 2019

Topic: Thrombosis, Platelets, and Coagulation

Session: New insights for acute coronary syndrome pharmacotherapy

Thumbnail

Impact of 2017 ACC/AHA new recommendation for blood pressure target goals on an hispanic population

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Environmental and global impacts on blood pressure

Thumbnail

Underuse of prasugrel and ticagrelor in patients with chronic kidney disease despite achieving a more effective platelet inhibition than clopidogrel

Event: ESC Congress 2017

Topic: Thrombosis and platelets

Session: Acute coronary syndromes

Thumbnail

Impact of insulin therapy on thienopyridine- and ticagrelor- mediated platelet inhibition in patients with an acute coronary syndrome

Event: ESC Congress 2017

Topic: Thrombosis and platelets

Session: Acute coronary syndromes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk